J. Goldman & Co LP - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is and the CUSIP is 834203309. A total of 21 filers reported holding SOLENO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,947,660
+275.8%
66,000
-45.4%
0.07%
+257.9%
Q2 2023$518,228
-10.1%
120,799
-55.2%
0.02%
-17.4%
Q1 2023$576,608
+158.9%
269,443
+139.5%
0.02%
+109.1%
Q4 2022$222,748
+197.0%
112,499
+150.0%
0.01%
+175.0%
Q3 2022$75,00044,9990.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 422,489$904,1270.33%
Clayton Partners LLC 92,772$198,5320.19%
Nantahala Capital Management 699,364$1,496,6390.12%
Worth Venture Partners, LLC 103,913$222,3740.11%
Carlyle Group Inc. 1,201,506$2,535,1780.08%
J. Goldman & Co LP 269,443$576,6080.02%
BANK OF AMERICA CORP /DE/ 2,093$4,4790.00%
WELLS FARGO & COMPANY/MN 38$810.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 37$790.00%
View complete list of SOLENO THERAPEUTICS INC shareholders